High CD123 levels enhance proliferation in response to IL-3, but reduce chemotaxis by downregulating CXCR4 expression
Nicole L Wittwer, Gabriela Brumatti, Ceilidh Marchant, Jarrod J Sandow, Melanie K Pudney, Mara Dottore, Richard J D'Andrea, Angel F Lopez, Paul G Ekert, Hayley S Ramshaw
Blood Advances | AMER SOC HEMATOLOGY | Published : 2017
Awarded by National Health and Medical Research Council
Awarded by Cancer Australia/Leukaemia Foundation
This work was supported by project grants from the National Health and Medical Research Council (1048071) (P.G.E. and H.S.R.), (1081376) (G.B.), (1071897) (A.F.L.); and the Cancer Australia/Leukaemia Foundation (1010336) (A.F.L. and H.S.R.). H.S.R. is supported by the Peter Nelson Leukaemia Research Fund. N.L.W. was supported by a Leukaemia Foundation of Australia PhD scholarship. G.B. is supported by a Victorian Cancer Agency MidCareer fellowship. This work was made possible through Victorian State Government Operational Infrastructure Support, and L.E.W. Carty Charitable Fund and Ian Rollo Currie Estate Foundation for infrastructure support.